BackLaboratorios Farmaceuticos Rovi, S.A. Overview
Laboratorios Farmaceuticos Rovi, S.A.

Laboratorios Farmaceuticos Rovi, S.A. Return on Equity

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) has a ROE of 26.43%, above the sector sector average of 11.75%.

Get informed when a big investor buys or sells

+ Follow

ROE

26.43%

Return on Equity

26.43%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) FAQ

As of the most recent data, LABFF shows a ROE of 26.43%. That is above the sector sector average of 11.75%. Scroll down for historical charts and peer comparison views.

The its sector sector average ROE is about 11.75%. Laboratorios Farmaceuticos Rovi, S.A. is at 26.43%, which is higher that average. That is roughly 124.9% above the sector mean. Use the comparison chart on this page to see how LABFF stacks up against individual peers as well.

Check the historical chart to see whether LABFF's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Laboratorios Farmaceuticos Rovi, S.A. with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Laboratorios Farmaceuticos Rovi, S.A.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 26.43%) with ownership activity and broader fundamentals.